Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!

WINT Insider Trading (Windtree Therapeutics)

Insider Ownership Percentage: 16.07%
Insider Buying (Last 12 Months): $474,605.62
Insider Selling (Last 12 Months): $0.00

Windtree Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Windtree Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Windtree Therapeutics Share Price & Price History

Current Price: $1.49
Price Change: Price Decrease of -0.14 (-8.59%)
As of 12/3/2021 01:00 AM ET

This chart shows the closing price history over time for WINT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
US Economy Faces New $1.4 Trillion Threat
Almost every electronic manufacturer depends on this one resource. And it's running dangerously low. It's not lithium. It's not gold. It's not hydrogen. But this new industry could be one of the best opportunities for investors in 2021.
See Why Tech Giants Are Hoarding This Resource

Windtree Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/18/2021Craig FraserCEOBuy930$1.61$1,497.30View SEC Filing Icon  
10/22/2021Craig FraserCEOBuy3,000$1.90$5,700.00View SEC Filing Icon  
10/19/2021Craig FraserCEOBuy3,000$1.91$5,730.00View SEC Filing Icon  
10/19/2021James HuangDirectorBuy50,000$1.90$95,000.00View SEC Filing Icon  
4/16/2021John P HamillCFOBuy1,000$2.07$2,070.0029,298View SEC Filing Icon  
4/7/2021Eric CurtisCOOBuy791$2.52$1,993.321,291View SEC Filing Icon  
4/5/2021Craig FraserCEOBuy1,000$2.58$2,580.0027,798View SEC Filing Icon  
3/31/2021Craig FraserCEOBuy500$2.32$1,160.0026,298View SEC Filing Icon  
3/31/2021James HuangDirectorBuy150,000$2.36$354,000.00171,000View SEC Filing Icon  
3/25/2021Steven SimonsonSVPBuy1,500$3.25$4,875.0012,302View SEC Filing Icon  
10/28/2020Craig FraserCEOBuy250$6.56$1,640.0024,298View SEC Filing Icon  
10/23/2020James HuangDirectorBuy1,000$6.67$6,670.0021,000View SEC Filing Icon  
10/9/2020Craig FraserCEOBuy250$5.83$1,457.5024,048View SEC Filing Icon  
10/8/2020Eric CurtisCOOBuy500$5.27$2,635.00500View SEC Filing Icon  
10/7/2020Craig FraserCEOBuy250$5.17$1,292.5023,798View SEC Filing Icon  
10/7/2020John P HamillCFOBuy1,000$5.27$5,270.001,000View SEC Filing Icon  
6/3/2020James HuangDirectorBuy200$7.42$1,484.008,000View SEC Filing Icon  
1/17/2020James HuangDirectorBuy2,058$4.45$9,158.10
12/30/2019James HuangDirectorBuy5,000$4.25$21,250.00
12/21/2018Lph Ii Investments LtdMajor ShareholderBuy1,810,938$3.31$5,994,204.78View SEC Filing Icon  
See Full Table
Insider Selling at Windtree Therapeutics?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Windtree Therapeutics and related companies.

SEC Filings (Institutional Ownership Changes) for Windtree Therapeutics (NASDAQ:WINT)

6.31% of Windtree Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at WINT by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Windtree Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/12/2021Renaissance Technologies LLC187,400$0.39M0.0%+28.6%0.702%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC158,747$0.33M0.0%+129.8%0.594%Search for SEC Filing on Google Icon
11/10/2021Skandinaviska Enskilda Banken AB publ 110,500$0.23M0.0%+15.7%0.414%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.49,708$0.10M0.0%-13.6%0.186%Search for SEC Filing on Google Icon
8/17/2021Citadel Advisors LLC12,984$30K0.0%-80.3%0.049%Search for SEC Filing on Google Icon
8/16/2021State Street Corp19,300$44K0.0%N/A0.072%Search for SEC Filing on Google Icon
8/16/2021Frontier Wealth Management LLC60,000$0.14M0.0%N/A0.225%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.66,952$0.15M0.0%N/A0.251%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC145,700$0.33M0.0%+1,156.0%0.546%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp65,380$0.15M0.0%+28.8%0.245%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC69,082$0.16M0.0%N/A0.259%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.626,057$1.43M0.0%+16.1%2.344%Search for SEC Filing on Google Icon
8/10/2021Skandinaviska Enskilda Banken AB publ95,500$0.22M0.0%N/A0.364%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC66,035$0.16M0.0%N/A0.251%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC66,035$0.16M0.0%N/A0.251%Search for SEC Filing on Google Icon
5/17/2021HRT Financial LP23,365$57K0.0%N/A0.089%Search for SEC Filing on Google Icon
5/14/2021PVG Asset Management Corp63,795$0.16M0.5%N/A0.243%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC11,600$28K0.0%N/A0.044%Search for SEC Filing on Google Icon
5/13/2021Kepos Capital LP165,000$0.40M0.0%+83.3%0.628%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp50,743$0.13M0.0%-29.9%0.193%Search for SEC Filing on Google Icon
5/4/2021Envestnet Asset Management Inc.36,334$89K0.0%N/A0.138%Search for SEC Filing on Google Icon
3/9/2021tru Independence LLC60,000$0.31M0.0%N/A0.355%Search for SEC Filing on Google Icon
2/16/2021Paloma Partners Management Co18,469$95K0.0%-50.2%0.109%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp72,385$0.37M0.0%-11.3%0.428%Search for SEC Filing on Google Icon
11/17/2020Paloma Partners Management Co37,090$0.20M0.0%N/A0.220%Search for SEC Filing on Google Icon
8/14/2020Deerfield Management Company L.P. Series C20,148$0.14M0.0%N/A0.147%Search for SEC Filing on Google Icon
7/31/2020UBS Group AG3,498$25K0.0%N/A0.026%Search for SEC Filing on Google Icon
5/15/2017Sabby Management LLC287,522$0.33M0.0%-14.0%3.046%Search for SEC Filing on Google Icon
5/15/2017Broadfin Capital LLC777,797$0.89M0.1%No Change8.240%Search for SEC Filing on Google Icon
2/14/2017Broadfin Capital LLC777,797$0.97M0.1%No Change9.176%Search for SEC Filing on Google Icon
2/10/2017FMR LLC224,091$0.28M0.0%No Change2.644%Search for SEC Filing on Google Icon
11/14/2016Baker BROS. Advisors LP254,973$0.65M0.0%N/A3.069%Search for SEC Filing on Google Icon
8/15/2016Sabby Management LLC448,509$0.87M0.0%N/A5.450%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Windtree Therapeutics logo
Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical and medical device company, which engages in the development of novel therapeutics intended to address significant unmet medical needs in important acute care markets. It focuses on the treatment of acute cardiovascular and acute pulmonary diseases. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA.
Read More on Windtree Therapeutics

Today's Range

Now: $1.49
Low: $1.48
High: $1.62

50 Day Range

MA: $1.88
Low: $1.49
High: $2.31

52 Week Range

Now: $1.49
Low: $1.46
High: $6.69

Volume

250,985 shs

Average Volume

1,157,362 shs

Market Capitalization

$42.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Windtree Therapeutics?

Windtree Therapeutics' top insider investors include:
  1. James Huang (Director)
  2. John P Hamill (CFO)
  3. Craig Fraser (CEO)
  4. Steven Simonson (SVP)
  5. Eric Curtis (COO)

Who are the major institutional investors of Windtree Therapeutics?

Windtree Therapeutics' top institutional investors include:
  1. Renaissance Technologies LLC — 0.70%
  2. Geode Capital Management LLC — 0.59%
  3. Skandinaviska Enskilda Banken AB publ — 0.41%
  4. BlackRock Inc. — 0.19%

Which major investors are selling Windtree Therapeutics stock?

During the last quarter, WINT stock was sold by these institutional investors:
  1. BlackRock Inc.

Which major investors are buying Windtree Therapeutics stock?

In the last quarter, WINT stock was acquired by institutional investors including:
  1. Geode Capital Management LLC
  2. Renaissance Technologies LLC
  3. Skandinaviska Enskilda Banken AB publ
Within the last year, these company insiders have bought Windtree Therapeutics stock:
  1. James Huang (Director)
  2. John P Hamill (CFO)
  3. Craig Fraser (CEO)
  4. Steven Simonson (SVP)
  5. Eric Curtis (COO)
Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!